These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9854332)

  • 1. [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine].
    Duswald KH; Pittrow L; Penk A
    Anaesthesiol Reanim; 1998; 23(5):134-8. PubMed ID: 9854332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose therapy with fluconazole > or = 800 mg/day. Review].
    Penk A; Pittrow L
    Mycoses; 1997; 40 Suppl 1():33-42. PubMed ID: 9417511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose therapy with fluconazole > or = 800 mg day-1.
    Duswald KH; Penk A; Pittrow L
    Mycoses; 1997 Nov; 40(7-8):267-77. PubMed ID: 9476509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
    de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
    Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease.
    Péter Z; Horváth Z; Makara M; Telegdy L; Zala J; Zágoni T
    Z Gastroenterol; 1996 Jun; 34(6):361-4. PubMed ID: 8767824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
    Sobel JD; Kapernick PS; Zervos M; Reed BD; Hooton T; Soper D; Nyirjesy P; Heine MW; Willems J; Panzer H; Wittes H
    Am J Obstet Gynecol; 2001 Aug; 185(2):363-9. PubMed ID: 11518893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose fluconazole therapy in Intensive Care Unit.
    De Bellis P; Bonfiglio M; Gerbi G; Bacigalupo P; Buscaglia G; Guido P; Massobrio B
    Minerva Anestesiol; 2003 Mar; 69(3):145-52, 153-57. PubMed ID: 12792583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
    Mondal RK; Singhi SC; Chakrabarti A; M J
    Pediatr Crit Care Med; 2004 Nov; 5(6):561-5. PubMed ID: 15530193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
    Rodríguez-Adrián LJ; King RT; Tamayo-Derat LG; Miller JW; Garcia CA; Rex JH
    Medicine (Baltimore); 2003 May; 82(3):187-202. PubMed ID: 12792305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.
    de Wet NT; Bester AJ; Viljoen JJ; Filho F; Suleiman JM; Ticona E; Llanos EA; Fisco C; Lau W; Buell D
    Aliment Pharmacol Ther; 2005 Apr; 21(7):899-907. PubMed ID: 15801925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing therapy for Candida infections.
    Playford EG; Sorrell TC
    Semin Respir Crit Care Med; 2007 Dec; 28(6):678-88. PubMed ID: 18095232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.